BioCentury
ARTICLE | Financial News

Revolution Medicines completes venture financing

December 22, 2016 5:24 PM UTC

Revolution raised $25 million from The Column Group in an extension of a series A round, bringing the total raised in the round to $70 million....

BCIQ Company Profiles

Revolution Medicines Inc.